As Canada looks to rebuild its biomanufacturing sector and support Canadian solutions to global health challenges, researchers at the University of Ottawa are partnering with the University of Alberta and BioCanRx to create Canada’s first full-service, end-to-end biomanufacturing solution for academic and industry clients.
The partnership is helping increase the country’s capacity to create Canadian solutions and bring life-saving medical treatments, therapies, clinical trials and vaccines to Canadians faster, including COVID-19 vaccines.
For more information, visit the University of Ottawa.